The ISCDx test uses gene expression to identify the cause of stroke during the hospital admission following acute treatment, to enable a targeted and personalized approach can be implemented to minimize the risk of recurrence.
Participate in the DxPx Pitch competition virtual juror and join DxPx Conference for 499 EUR.
